Brian Nowosielski

This episode highlights the landmark FTC settlement with Express Scripts and what independent pharmacies and plan sponsors can expect going forward.

With efforts to further scale naloxone access in US community pharmacies, researchers explore the implementation of a hub-and-spoke distribution model.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, provides nuance and understanding to the FDA’s recent push to move, essentially, ‘every’ drug to OTC formulation.

Along with presenting best practices for pharmacies’ vaccination workflows, researchers explore the impact of community pharmacies offering technician-administered vaccines.

In an exploration of the drug stigma scale, researchers assess its ability to address factors associated with stigma levels regarding OTC misuse.

With the OPUS-1, 2, and 3 trials underway, Vax-31 has the potential to become the first pneumococcal vaccine of its kind, demonstrating never-before-seen impacts on disease burden.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.

In Texas community pharmacies, researchers assess the communication concordance between pharmacists and patients during medication counseling.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.

Annie Lambert, PharmD, BCSCP, discusses pharmacies’ regulation and compliance needs when it comes to dispensing compounded GLP-1s.

Investigators used a large cohort of patients from Taiwan between 2004 and 2015 to determine the potential link between Tylenol use and childhood neurodevelopment.

CDC researchers investigate pneumococcal disease cases and intervention strategies within a North Carolina correctional facility from June 14 to July 30, 2024.

The health care landscape for metabolic liver disease is undergoing a shift, and pharmacists are being positioned at the forefront of this therapeutic revolution.

Annie Lambert, PharmD, BCSCP, discusses the key approaches to ensuring safe and effective dispensing of compounded GLP-1 medications.

From patient perspectives on acceptability, researchers assess the impact of pharmacist-led point-of-care testing services in rural Tennessee communities.

Researchers investigate PCV25 developments and potential use of the vaccine among adults who are healthy and naïve to the pneumococcal vaccine.

Amid increased use of artificial intelligence across pharmacy, researchers assess pharmacists’ propensity to trust the emerging automated technology.

With drug shortages continuing to disrupt patient care and pharmacy operations, Lani Bertrand breaks down how AI and automation are reshaping the way pharmacies respond to supply chain disruptions.

Highlighting 'prone to abuse' and adverse effects as the driver of this bill, Senator Hawley aims to reverse an FDA decision made over 25 years ago.

Drug shortages remain one of the most persistent challenges in pharmacy practice, but emerging technologies like AI are beginning to shift the landscape for pharmacies and public health as a whole.

In regard to potentially dangerous exposure to parabens, researchers aim to clarify the role of OTC liquid drugs among children.

This episode explores a specific generalization within pharmacy practice that leaders should actively avoid while simultaneously looking toward overcoming key hurdles affecting team members.

Through the lens of geographic and racial accessibility, researchers explore OTC naloxone sales and costs in North Carolina.

Pneumococcal aortitis is a rare but life-threatening aortic infection that highlights the concerning interplay between pneumococcal disease and cardiovascular disease risk and mortality.

Lani Bertrand, senior director of clinical marketing & thought leadership at Omnicell, discusses the consistent drivers of drug shortages in the US.

Researchers explore the serotypes, vaccination, and risk factors associated with pneumococcal disease mortality among in-hospital patients in Spain.

With its initial rollout beginning in 2026, the Medicare Drug Price Negotiation Program has caused significant strain on the cash flow of independent pharmacies.

With a growing prevalence of medication use across the US, researchers explore overall use of OTC and prescription drugs from June 2023 to April 2024.

With a key exemption under DSCSA expiring at the end of the year, Matt Sample from Cencora helps pharmacies understand the tools and processes they need now to best comply with the law.

Pharmacists are taking the lead to combat misinformation on measles and preserve the nation’s fragile elimination status.